Hypertension Due to Blockade of Adenosine Receptors*
Open Access
- 11 April 2003
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 92 (4) , 160-162
Abstract
Chronic treatment of rats with 90 μg/kg/day DPSPX (1,3‐dipropyl‐8‐sulphophenylxanthine) during seven days leads to a hypertensive state which is characterized by marked morphological changes of the blood vessel walls as well as by important functional alterations. While the angiotensin‐converting enzyme (ACE) inhibitor captopril and the antagonist of angiotensin II AT 1 receptors losartan prevent the development of both hypertension and morphological changes, the selective β1‐adrenoceptor antagonist atenolol could prevent only the increase in blood pressure. It is concluded that at least two factors are involved in the development of the hypertensive state.Keywords
This publication has 7 references indexed in Scilit:
- Hypertension due to chronic blockade of P1‐purinoceptorsJournal of Autonomic Pharmacology, 1996
- Modulation by nicotinamide adenine dinucleotide of sympathetic and sensory-motor neurotransmission via P1-purinoceptors in the rat mesenteric arterial bedBritish Journal of Pharmacology, 1995
- Hypertension and enhanced β-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptorsBritish Journal of Pharmacology, 1995
- Long-term administration of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) alters ?2-adrenoceptor-mediated effects at the pre- but not at the postjunctional levelNaunyn-Schmiedeberg's Archives of Pharmacology, 1994
- Purine agonists prevent trophic changes caused by sympathetic denervationEuropean Journal of Pharmacology, 1990
- Endogenous adenosine restrains renin release in conscious rats.Circulation Research, 1990
- A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitterNaunyn-Schmiedeberg's Archives of Pharmacology, 1978